✦ LIBER ✦

BIOCHEMICAL STUDIES IN HUNTINGTON'S CHOREA : II. Composition of Blood Lipids

✍ Scribed by G. J. M. Hooghwinkel; P. F. Borri; G. W. Bruyn

Book ID: 114779579
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 361 KB
Volume: 42
Category: Article
ISSN: 0001-6314
DOI: 10.1111/j.1600-0404.1966.tb01177.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Quantitative study of gliosis in schizop

Quantitative study of gliosis in schizophrenia and huntington's chorea

✍ Carl D. Stevens; Lori L. Altshuler; Bernhard Bogerts; Peter Falkai 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 367 KB

Neurophysiological study of facial chore

Neurophysiological study of facial chorea in patients with Huntington's disease

✍ Esteban Muñoz; Alvaro Cervera; Josep Valls-Solé 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 408 KB

Electron spin resonance studies of eryth

Electron spin resonance studies of erythrocyte ghost cells in Huntington's chorea

✍ G. C. Beverstock; P. L. Pearson 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 580 KB

Association and linkage studies of Hunti

Association and linkage studies of Huntington's chorea in relation to fifteen genetic markers

✍ L. BECKMAN; B. CEDERGREN; B. MATTSSON; J.-O. OTTOSSON 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 277 KB

Comparative studies on blood-stream and

Comparative studies on blood-stream and culture forms of Trypanosoma lewisi— II. Biochemical composition

✍ J.S. Hibbard; D.G. Dusanic 📂 Article 📅 1970 🏛 Elsevier Science ⚖ 842 KB

Open-label pilot study of levetiracetam

Open-label pilot study of levetiracetam (Keppra) for the treatment of chorea in Huntington's disease

✍ Theresa A. Zesiewicz; Kelly L. Sullivan; Robert A. Hauser; Juan Sanchez-Ramos 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB 👁 1 views

## Abstract The objective of this study is to evaluate the tolerability and preliminary efficacy of levetiracetam (LEV) in reducing chorea in Huntington's disease (HD) patients in a prospective open‐label pilot study. Nine HD patients with chorea were treated with LEV in doses up to 3,000 mg/day fo